Medpace
MEDP
337 hedge funds and large institutions have $5.42B invested in Medpace in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 139 increasing their positions, 116 reducing their positions, and 20 closing their positions.
85% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 20
48% more call options, than puts
Call options by funds: $25.2M | Put options by funds: $17M
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
20% more repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 116
11% more capital invested
Capital invested by funds: $4.87B → $5.42B (+$546M)
4% more funds holding
Funds holding: 324 → 337 (+13)
3.17% more ownership
Funds ownership: 76.73% → 79.91% (+3.2%)
Top Buyers
Top Sellers
| 1 |
PG
Pendal Group
Sydney,
Australia
|
-$115M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$34.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.4M |
| 4 |
BCA
Bernzott Capital Advisors
Camarillo,
California
|
-$12.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.1M |
MEDP Hedge Fund Activity: Q3 2021 in Review
337 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2021, worth a combined $5.42B — up 11% from $4.87B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new MEDP positions and 20 closed out — a net gain of 17 holders — while 139 added to existing stakes and 116 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $179M. The largest seller was Pendal Group, cutting an estimated $115M.
- 337 institutional investors held Medpace (MEDP) as of Q3 2021, up from 324 in Q2 2021.
- Funds reported $5.42B of Medpace stock for Q3 2021, up 11% quarter-over-quarter.
- 37 funds opened new Medpace positions in Q3 2021 and 20 closed out, a net change of +17 holders.
- The largest Medpace buyer in Q3 2021 was Wellington Management Group, an estimated $179M added.
- The largest Medpace seller in Q3 2021 was Pendal Group, an estimated $115M sold.
Based on aggregated 13F filings for Q3 2021.